{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:22:43Z","timestamp":1771510963307,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40256-025-00772-7","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:06:06Z","timestamp":1760519166000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Midodrine to Facilitate Guideline-Directed Medical Therapy in Heart Failure with Reduced Ejection Fraction: A Promising Breakthrough or Just a False Hope?"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3316-5621","authenticated-orcid":false,"given":"Muhammad","family":"Sanusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ndakotsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinakaran","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prami","family":"Nakarmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopeessh","family":"Vempati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf Kamran","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utheja","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetha","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789\u20131858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7","DOI":"10.1016\/S0140-6736(18)32279-7"},{"issue":"8","key":"772_CR2","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254\u2013743. https:\/\/doi.org\/10.1161\/CIR.0000000000000950.","journal-title":"Circulation"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacc.2022.05.033","volume":"80","author":"R Mohebi","year":"2022","unstructured":"Mohebi R, Chen C, Ibrahim NE, et al. Cardiovascular disease projections in the United States based on the 2020 census estimates. J Am Coll Cardiol. 2022;80:565\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.033.","journal-title":"J Am Coll Cardiol"},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021;42:681\u20133. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1012.","journal-title":"Eur Heart J"},{"issue":"18","key":"772_CR5","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1161\/CIR.0000000000001062","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e876\u201394. https:\/\/doi.org\/10.1161\/CIR.0000000000001062.","journal-title":"Circulation"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10557-017-6764-8","volume":"31","author":"EB Levitan","year":"2017","unstructured":"Levitan EB, Van Dyke MK, Loop MS, et al. Barriers to beta-blocker use and up-titration among patients with heart failure with reduced ejection fraction. Cardiovasc Drugs Ther. 2017;31:559\u201364. https:\/\/doi.org\/10.1007\/s10557-017-6764-8.","journal-title":"Cardiovasc Drugs Ther"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, et al. Orthostatic hypotension. J Am Coll Cardiol. 2018;72:1294\u2013309. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.079.","journal-title":"J Am Coll Cardiol"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1517\/14656566.1.4.835","volume":"1","author":"DN Cruz","year":"2000","unstructured":"Cruz DN. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension. Expert Opin Pharmacother. 2000;1:835\u201340. https:\/\/doi.org\/10.1517\/14656566.1.4.835.","journal-title":"Expert Opin Pharmacother"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1136\/bmjspcare-2020-002369","volume":"13","author":"A Gonzalez-Cordero","year":"2023","unstructured":"Gonzalez-Cordero A, Ortiz-Troche S, Nieves-Rivera J, et al. Midodrine in end-stage heart failure. BMJ Support Palliat Care. 2023;13:e86\u20137. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002369.","journal-title":"BMJ Support Palliat Care"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"H725","DOI":"10.1152\/ajpheart.00621.2020","volume":"320","author":"J Zhang","year":"2021","unstructured":"Zhang J, Simpson PC, Jensen BC. Cardiac \u03b11A-adrenergic receptors: emerging protective roles in cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2021;320:H725\u201333. https:\/\/doi.org\/10.1152\/ajpheart.00621.2020.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"772_CR12","doi-asserted-by":"publisher","unstructured":"The Allhat Officers And Coordinators For The Allhat Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000;283:1967\u20131975. https:\/\/doi.org\/10.1001\/jama.283.15.1967","DOI":"10.1001\/jama.283.15.1967"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1.","journal-title":"Lancet"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ejhf.1459","volume":"21","author":"M Komajda","year":"2019","unstructured":"Komajda M, Sch\u00f6pe J, Wagenpfeil S, et al. Physicians\u2019 guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2019;21:921\u20139. https:\/\/doi.org\/10.1002\/ejhf.1459.","journal-title":"Eur J Heart Fail"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/FJC.0000000000001532","volume":"83","author":"CB Scoma","year":"2024","unstructured":"Scoma CB, Lee DH, Money D, et al. The impact of midodrine on guideline-directed medical therapy in patients admitted with systolic heart failure. J Cardiovasc Pharmacol. 2024;83:353\u20138. https:\/\/doi.org\/10.1097\/FJC.0000000000001532.","journal-title":"J Cardiovasc Pharmacol"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/00015385.2024.2365608","volume":"79","author":"N Patel","year":"2024","unstructured":"Patel N, Alvarez Concejo B, Lo KB, et al. Outcomes with inpatient use of midodrine in patients with heart failure and kidney failure on maintenance dialysis. Acta Cardiol. 2024;79:545\u20138. https:\/\/doi.org\/10.1080\/00015385.2024.2365608.","journal-title":"Acta Cardiol"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1097\/CCM.0000000000003814","volume":"47","author":"MS Rizvi","year":"2019","unstructured":"Rizvi MS, Nei AM, Gajic O, et al. Continuation of newly initiated midodrine therapy after intensive care and hospital discharge: a single-center retrospective study. Crit Care Med. 2019;47:e648\u201353. https:\/\/doi.org\/10.1097\/CCM.0000000000003814.","journal-title":"Crit Care Med"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.cardfail.2020.09.175","volume":"26","author":"K Vijayaraghavan","year":"2020","unstructured":"Vijayaraghavan K, Little D, Mercer T, et al. Midodrine as a bridge to enable use of life enhancing therapies in chronic heart failure. J Card Fail. 2020;26:S59. https:\/\/doi.org\/10.1016\/j.cardfail.2020.09.175.","journal-title":"J Card Fail"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-7133.2008.00042.x","volume":"15","author":"RM Zakir","year":"2009","unstructured":"Zakir RM, Folefack A, Saric M, Berkowitz RL. The use of midodrine in patients with advanced heart failure. Congest Heart Fail. 2009;15:108\u201311. https:\/\/doi.org\/10.1111\/j.1751-7133.2008.00042.x.","journal-title":"Congest Heart Fail"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MAJ.0b013e3181b7efa7","volume":"338","author":"SM Bergman","year":"2009","unstructured":"Bergman SM. Hemodialysis in hypotensive heart failure using midodrine. Am J Med Sci. 2009;338:470\u20133. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181b7efa7.","journal-title":"Am J Med Sci"},{"key":"772_CR21","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003246","volume":"9","author":"A Hajjiah","year":"2022","unstructured":"Hajjiah A, Maadarani O, Bitar Z, et al. Use of midodrine in heart failure: two case reports and a review of the literature. Eur J Case Rep Intern Med. 2022;9:003246. https:\/\/doi.org\/10.12890\/2022_003246.","journal-title":"Eur J Case Rep Intern Med"},{"key":"772_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X221100400","volume":"10","author":"P Shiu","year":"2022","unstructured":"Shiu P, Grewal GS, Kozik TM. Midodrine to optimize heart failure therapy in patients with concurrent hypotension. SAGE Open Med Case Rep. 2022;10:2050313X221100400. https:\/\/doi.org\/10.1177\/2050313X221100400.","journal-title":"SAGE Open Med Case Rep"},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/jcpt.12375","volume":"41","author":"LB Poveromo","year":"2016","unstructured":"Poveromo LB, Michalets EL, Sutherland SE. Midodrine for the weaning of vasopressor infusions. J Clin Pharm Ther. 2016;41:260\u20135. https:\/\/doi.org\/10.1111\/jcpt.12375.","journal-title":"J Clin Pharm Ther"},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1097\/MS9.0000000000000922","volume":"85","author":"S Gautam","year":"2023","unstructured":"Gautam S, Lamichhane S, Sharma NR, et al. Use of midodrine in heart failure: a review. Ann Med Surg. 2023;85:2808\u201313. https:\/\/doi.org\/10.1097\/MS9.0000000000000922.","journal-title":"Ann Med Surg"},{"key":"772_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2022.08.031","volume":"105","author":"FJ Fern\u00e1ndez-Fern\u00e1ndez","year":"2022","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez FJ, Ameneiros-Lago E, Sardina-Ferreiro R. Might midodrine be useful in patients with decompensated and worsening chronic heart failure? Eur J Intern Med. 2022;105:104. https:\/\/doi.org\/10.1016\/j.ejim.2022.08.031.","journal-title":"Eur J Intern Med"},{"key":"772_CR26","unstructured":"Ottawa Heart Institute Research Corporation. Midodrine in heart failure with reduced ejection fraction with hypotension (MIDOH-HF-P): a pilot, open-label, randomized controlled trial. NCT06405555. clinicaltrials.gov; 2024. https:\/\/www.clinicaltrials.gov\/study\/NCT06405555"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-025-00772-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:23:56Z","timestamp":1771507436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-025-00772-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s40256-025-00772-7","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Muhammad Sanusi, Andrew Ndakotsu, Dinakaran Umashankar, Prami Nakarmi, Roopeessh Vempati, Ravi Patel, Yash Varma, Yusuf Kamran Qadeer, Utheja Dasari, and Geetha Krishnamoorthy have no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"MS, AN, DU, PN, RV, UD, and RP contributed to the initial drafting of the manuscript. MS and GK developed the concept and design of the review and provided critical revisions and editorial oversight throughout the writing process. MS conceptualized and created the central illustration. MS, YKQ, and YV undertook the final revisions and editing of the manuscript. All authors reviewed and approved the final version of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}